Is It Too Late To Consider Buying CONMED Corporation (NYSE:CNMD)?
Is It Too Late To Consider Buying CONMED Corporation (NYSE:CNMD)?
While CONMED Corporation (NYSE:CNMD) might not have the largest market cap around , it saw significant share price movement during recent months on the NYSE, rising to highs of US$115 and falling to the lows of US$80.91. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether CONMED's current trading price of US$81.02 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at CONMED's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
尽管CONMED Corporation（纽约证券交易所代码：CNMD）的市值可能不是最大的，但近几个月来，纽约证券交易所的股价出现了大幅波动，升至115美元的高位，跌至80.91美元的低点。一些股价走势可以为投资者提供更好的入股机会，并有可能以较低的价格买入。需要回答的问题是，CONMED目前的81.02美元交易价格是否反映了中型股的实际价值？还是它目前的估值被低估了，为我们提供了买入的机会？让我们根据最新的财务数据来看看CONMED的前景和价值，看看是否有任何价格变动的催化剂。
What's The Opportunity In CONMED?
CONMED 的机会是什么？
According to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. We find that CONMED's ratio of 38.65x is trading slightly above its industry peers' ratio of 35.94x, which means if you buy CONMED today, you'd be paying a relatively sensible price for it. And if you believe CONMED should be trading in this range, then there isn't really any room for the share price grow beyond the levels of other industry peers over the long-term. Is there another opportunity to buy low in the future? Since CONMED's share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.
根据我们的价格倍数模型，该模型将公司的市盈率与行业平均水平进行了比较，股价似乎是合理的。在这种情况下，鉴于没有足够的信息来可靠地预测股票的现金流，我们使用了市盈率（PE）。我们发现，CONMED的38.65倍比率略高于其行业同行35.94倍的比率，这意味着如果你今天买入CONMED，你将为此付出相对合理的价格。而且，如果你认为CONMED应该在这个区间内交易，那么从长远来看，股价实际上没有任何超出其他行业同行的上涨空间。未来还有其他低价买入的机会吗？由于CONMED的股价波动很大，未来我们可能会看到其下跌（或上涨），这为我们提供了另一个买入机会。这是基于其较高的贝塔值，这是一个很好的指标，可以很好地衡量股票相对于其他市场的波动幅度。
What kind of growth will CONMED generate?
CONMED 将带来什么样的增长？
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. CONMED's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.
寻求投资组合增长的投资者可能需要在购买公司股票之前考虑公司的前景。以低廉的价格收购一家前景看好的优秀公司永远是一项不错的投资，因此，让我们也来看看公司的未来预期。CONMED未来几年的收益预计将翻一番，这表明未来非常乐观。这应该会导致更强劲的现金流，从而提高股票价值。
What This Means For You
这对你意味着什么
Are you a shareholder? CNMD's optimistic future growth appears to have been factored into the current share price, with shares trading around industry price multiples. However, there are also other important factors which we haven't considered today, such as the track record of its management team. Have these factors changed since the last time you looked at CNMD? Will you have enough conviction to buy should the price fluctuate below the industry PE ratio?
你是股东吗？CNMD乐观的未来增长似乎已被纳入当前股价的因素，股票的交易价格约为行业价格倍数。但是，我们今天还没有考虑其他重要因素，例如其管理团队的往绩。自从你上次查看CNMD以来，这些因素是否发生了变化？如果价格波动低于行业市盈率，您是否有足够的信心买入？
Are you a potential investor? If you've been keeping tabs on CNMD, now may not be the most advantageous time to buy, given it is trading around industry price multiples. However, the optimistic forecast is encouraging for CNMD, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
你是潜在的投资者吗？如果您一直在关注CNMD，那么鉴于CNMD的交易价格约为行业倍数，现在可能不是最有利的买入时机。但是，CNMD的乐观预测令人鼓舞，这意味着值得深入研究其他因素，例如资产负债表的强度，以便利用下一次价格下跌的机会。
Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of CONMED.
请记住，在分析股票时，值得注意所涉及的风险。例如，我们发现了 1 个警告标志，为了更好地了解 CONMED，你应该把视线移过去。
If you are no longer interested in CONMED, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
如果您不再对CONMED感兴趣，可以使用我们的免费平台查看我们的其他50多只具有高增长潜力的股票清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗？对内容感到担忧？直接联系我们。 或者，给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论，我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议，也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意，我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之，华尔街没有持有任何上述股票的头寸。